secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0000947871-25-000317
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics provides long-term outlook: 4-5% revenue CAGR; reaffirms FY2025 guidance but notes Q1 weather headwind
--------------------------------------------------------------------------------

- Long-term outlook: revenue CAGR 4-5%, adjusted EPS CAGR 7-9% beyond 2025.
- Reaffirms FY2025 guidance: revenue $10.70B-$10.85B, adjusted EPS $9.55-$9.80.
- Q1 2025 weather headwind of ~$25M revenue and ~$0.10 EPS expected.
- Strategic initiatives include Invigorate productivity (3% annual savings) and Project Nova IT modernization.
- Double-digit growth targeted in advanced diagnostics: oncology, cardiometabolic, brain health, others.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000094787125000317/0000947871-25-000317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000094787125000317/ss4592500_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-25-000317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer